Cargando…
Cutaneous amyloid is a biomarker in early ATTRv neuropathy and progresses across disease stages
OBJECTIVE: To determine the sensitivity and specificity of cutaneous amyloid deposition in relation to patient‐reported measures in the earliest disease stage of hereditary ATTR amyloidosis (ATTRv). METHODS: In a cross‐sectional study, we analyzed 88 individuals with TTR mutations, 47 of whom were i...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463946/ https://www.ncbi.nlm.nih.gov/pubmed/35945901 http://dx.doi.org/10.1002/acn3.51636 |